Skip to main content
  1. Home
  2. News

FDA authorizes experimental drug remdesivir as coronavirus treatment

Jenny McGrath
By

The Food and Drug Administration (FDA) granted emergency use authorization (EAU) of remdesivir as a treatment for coronavirus on Friday, citing promising test results.

“The data shows that remdesivir has a clear-cut, significant, positive effect in diminishing the time to recovery,” Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, said Friday. The EAU is not the same as approval, which requires more testing and peer review.

Recommended Videos
<strong>Finding a fix: The race for a coronavirus cure</strong>
Coronavirus is wreaking havoc on the world, and will continue to for months to come — but what exactly are we doing to fight it? Have we made any progress on a vaccine? Here’s what you need to know
coronavirus taiwan asia technology success science researcher getty

Remdesivir was developed by pharmaceutical company Gilead Sciences in 2013. The antiviral drug was originally designed to fight the Ebola virus. In the rush to develop new treatments for COVID-19, researchers turned to remdesivir, as it was previously shown as a promising drug for MERS and SARS. “It is currently the most promising antiviral drug in development for the treatment of SARS-CoV-2, the coronavirus that causes COVID-19,” Dr. Melissa Maginnis, a research scientist from the University of Maine who specializes in molecular virology and viral pathogenesis, recently told Digital Trends.

Remdesivir vial
The Food and Drug Administration (FDA) approved remdesivir as a treatment for coronavirus on Friday. (Photo by Ulrich Perrey/Pool/AFP via Getty Images) Ulrich Perrey / Getty

An antiviral drug, remdesivir prevents the SARS-CoV-2 virus from making copies of itself. Remdesivir is a nucleotide analog that mimics adenosine, a building block of RNA and DNA. When the virus infects a cell and starts copying itself, remdesivir takes the place of adenosine, interfering with the process.

Early study results released Wednesday showed promising results in treating patients with remdesivir versus a placebo. They had faster recovery rates, an average of 11 days versus 15. The difference in death rates were not statistically significant, according to The Washington Post.

The study only included 1,063 patients, so it remains to be seen how it will affect a wider range of individuals.

Correction: An earlier version of this article misstated remdesivir’s FDA status. The agency has authorized it for use as a COVID-19 treatment.

Editors' Recommendations

Topics
Jenny McGrath
Jenny McGrath
Former Digital Trends Contributor
Jenny McGrath is a senior writer at Digital Trends covering the intersection of tech and the arts and the environment. Before…
NYC’s Mount Sinai Hospital using Google Nest to monitor coronavirus patients

Mount Sinai, one of New York City’s hospitals hit hardest by the coronavirus pandemic, is using Google's Nest cameras to monitor patients while limiting the exposure of its workers to the virus.

The health care giant has partnered with Google to install Nest Cams in the rooms of patients with COVID-19, the disease caused by the coronavirus, to help workers better monitor vital signs and reduce the exposure of first responders.

Read more
FDA authorizes at-home coronavirus test that uses your spit
Rutgers Spectrum Coronavirus Saliva Test.

The Food and Drug Administration has authorized a second at-home test for the coronavirus -- one that can detect the virus using saliva samples.

The test is made by a Rutgers University laboratory, RUCDR Infinite Biologics, in partnership with Spectrum Solutions and Accurate Diagnostic Labs. The Rutgers test uses a saliva collection device and must be sent back to the lab for testing. You can only receive the test if it’s been ordered through a physician.

Read more
Coronavirus antibody tests aren’t created equal. Here’s what you need to know
Researcher in Lab with Blood Sample Test

The Food and Drug Administration (FDA) recently decided to tighten the regulations on coronavirus antibody tests. These tests are supposed to help people know whether they were previously infected with the virus, but the FDA admitted that many of them aren’t accurate enough to be useful.

Whether you’ve already been administered an antibody test or hope to get one in the future, here’s what you need to know about whether to trust the results.
What are antibodies?
When your body is exposed to an antigen -- or outside substance including viruses, bacteria, and certain chemicals -- it causes the immune system to attack it. As part of the response, white blood cells create a certain kind of protein called antibodies. These proteins can only bind to that specific type of antigen, and they can help the body more quickly respond to the virus or bacteria, making you less likely to get sick from the exact same strain twice.

Read more